Expression of basal and luminal epithelium-specific keratins in normal, benign, and malignant breast tissue.
about
Keratins as markers that distinguish normal and tumor-derived mammary epithelial cellsMolecular Portrait of the Normal Human Breast Tissue and Its Influence on Breast CarcinogenesisOf mice and women: a comparative tissue biology perspective of breast stem cells and differentiationTranscription profiles of non-immortalized breast cancer cell lines.Tissue architecture and breast cancer: the role of extracellular matrix and steroid hormonesGlutamine synthetase is a genetic determinant of cell type-specific glutamine independence in breast epithelia.Mutation of GATA3 in human breast tumors.Mapping the cellular and molecular heterogeneity of normal and malignant breast tissues and cultured cell linesClear cell carcinoma of the breast with solid papillary pattern: a case report with immunohistochemical profile.Analysis of tumor environmental response and oncogenic pathway activation identifies distinct basal and luminal features in HER2-related breast tumor subtypes.Detection of basement membrane components and basal cell keratin 14 in noninvasive and invasive carcinomas of the breastBasal cell-specific and hyperproliferation-related keratins in human breast cancerBreast cancer gene expression profiling: clinical trial and practice implications.Mammary epithelial cells isolated from milk are a valuable, non-invasive source of mammary transcriptsUpdate on triple-negative breast cancer: prognosis and management strategiesCGH analysis of ductal carcinoma of the breast with basaloid/myoepithelial cell differentiation.Cytokeratin intermediate filament expression in benign and malignant breast disease.Biomarkers for Basal-like Breast Cancer.Myosin 1e promotes breast cancer malignancy by enhancing tumor cell proliferation and stimulating tumor cell de-differentiation.Triple-negative breast cancer--current status and future directions.FOXC1 regulates the functions of human basal-like breast cancer cells by activating NF-κB signaling.Basal-like breast cancer defined by FOXC1 expression offers superior prognostic value: a retrospective immunohistochemical study.Expression of basal keratins and vimentin in breast cancers of young women correlates with adverse pathologic parameters.Analysis of methylation-sensitive transcriptome identifies GADD45a as a frequently methylated gene in breast cancer.The limited difference between keratin patterns of squamous cell carcinomas and adenocarcinomas is explicable by both cell lineage and state of differentiation of tumour cellsDifferent proliferative activity of the glandular and myoepithelial lineages in benign proliferative and early malignant breast diseases.Immunohistochemical reactivity of basal and luminal epithelium-specific cytokeratin antibodies within normal and neoplastic canine mammary glands.Impact of breast cancer molecular subtypes on locoregional recurrence in patients treated with neoadjuvant chemotherapy for locally advanced breast cancer.Molecular signature of the putative stem/progenitor cells committed to the development of the bovine mammary gland at puberty
P2860
Q24558734-C7DC6CD7-9F0B-4E58-A351-B417AADCCFD8Q26744296-CD87BFF7-DA79-4B80-AEEA-B35BC3C00D58Q26796835-B1730D09-81D9-4649-A8A0-51794D06B167Q33240474-559A29FC-D727-438E-A159-8ECF537FE3DDQ33974007-278C8B97-7130-46BB-9AFD-229A09576BF3Q33996661-0953D6F3-B570-4D73-A582-3BB77F114055Q34347579-377C1C57-A730-4EC6-8507-60A9B5B8CE16Q34989167-3C2CED2E-6E31-48E7-AD4F-28E039DB0312Q35166635-B2908A51-31BF-4885-AAFB-FFDC02699F0CQ35558105-7E82D4E6-E2A3-44B0-B275-148B5854A865Q35815965-F51833AF-882A-4BD4-90A6-331AF1A04ACEQ35831039-283CD8AC-1697-4FCB-8018-375052F59D99Q36050579-956E96E5-DC50-456F-8E1D-C9A6568616B0Q36216020-31858C23-8F49-48DB-B7CE-A505D068544AQ36311616-BD662A8C-E136-4F31-BDEE-E2B16FB22DC4Q36623521-C624A1A0-72D1-4570-B349-695FD95C5A51Q37255237-F830CC7F-7622-4A2C-AA08-B2B865015B7FQ37328394-132DF68B-AAF8-4ABC-AB7E-38ED0D0E7E1AQ37564758-C283DA6A-2A71-4271-B0DD-91C91245715EQ37630082-FF904AEC-1FAF-4F36-98D7-EE480F7B7F07Q37651856-F1693741-5676-44E7-B80F-F7061A612B81Q38411253-E4A73C7B-D8A5-4FC7-9666-1B964F36F08DQ39974519-3FBF3F09-7EB7-4B2B-8CB0-CB13A427C9BBQ40453415-78CBBBB0-206E-4A83-A307-3ACC5FFD6BA2Q41450034-97E23A32-E898-4D49-86E5-C2169A5682E3Q42464623-E8B36558-BFA9-4EB6-9CED-6DD18E0E7676Q42483017-633C63D7-743B-4623-923A-2A31441786A3Q42485941-C7A49388-8CF9-4C31-BD9C-5DFB1BA719E0Q58577564-0328FBC8-885B-4CB3-A8F7-8977C75CCB08
P2860
Expression of basal and luminal epithelium-specific keratins in normal, benign, and malignant breast tissue.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
Expression of basal and lumina ...... , and malignant breast tissue.
@en
Expression of basal and lumina ...... , and malignant breast tissue.
@nl
type
label
Expression of basal and lumina ...... , and malignant breast tissue.
@en
Expression of basal and lumina ...... , and malignant breast tissue.
@nl
prefLabel
Expression of basal and lumina ...... , and malignant breast tissue.
@en
Expression of basal and lumina ...... , and malignant breast tissue.
@nl
P356
P1476
Expression of basal and lumina ...... n, and malignant breast tissue
@en
P2093
P304
P356
10.1093/JNCI/80.9.691
P407
P577
1988-07-01T00:00:00Z